2025.6-至今，同济大学医学院，副教授，博导；
Medicine School of Tongji University, associate Professor and Ph.D. Supervisor
同济大学医学院 副教授，博导。主要从事肿瘤发生发展过程中DNA损伤应答通路与基因组不稳定性，肿瘤放化疗耐药的分子机制研究。目前主持国家自然科学基金青年项目，入选国家博士后创新人才支持计划及上海市“超级博士后”激励计划人才项目。相关研究工作以第一作者（含共同）身份发表在Cell，Journal of Cell Biology，Science Advances，Cancer Letters等期刊上，申请专利两项，相关研究成果入选年度Cell最佳论文和中国生命科学十大进展。
An associate professor and doctoral supervisor at the School of Medicine, Tongji University. She research focuses on the DNA damage response pathway, genomic instability during tumor initiation and progression, and the molecular mechanisms underlying tumor resistance to radiotherapy and chemotherapy. Currently, she leading a Young Scientists Fund project of the National Natural Science Foundation of China (NSFC). Meanwhile, she has been selected into the National Postdoctoral Program for Innovative Talents and Shanghai’s "Super Postdoc" Incentive Program. In recent years, as the first author (including co-first), has published many SCI-indexed papers in journals such as Cell, Science Advances, Journal of Cell Biology, and Cancer Letters. She has applied for two patents, and her relevant research achievements have been selected as the Best of Cell and one of the top ten scientific advances in life sciences in China.
